A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum
This commentary reflects on what it means to do public health and social science research in a post-Covid world. Given the global urgency brought on by the pandemic, it appears as if any kind of non-Covid research has become redundant or meaningless